Cargando…
BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options
In the past 25 years, treatment of metastatic colorectal cancer (mCRC) has undergone profound changes. The approval of newer chemotherapeutics such as irinotecan and oxaliplatin was followed in 2005 by the first targeted therapies, for example, monoclonal antibodies directed against the epidermal gr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571135/ https://www.ncbi.nlm.nih.gov/pubmed/34259881 http://dx.doi.org/10.1007/s00292-021-00946-5 |